Expand PPCB Menu
PPCB MENU

PPCB Latest Press Releases

-- January 27, 2026 --

Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months - Strengthening Global Protection for Breakthrough Proenzyme Formulations Globe Newswire 8:45 AM

-- January 20, 2026 --

Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia Globe Newswire 8:45 AM

-- January 15, 2026 --

Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer Globe Newswire 8:45 AM

-- January 13, 2026 --

Propanc Biopharma Provides Shareholder Update Globe Newswire 8:45 AM

-- December 22, 2025 --

Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal Globe Newswire 7:00 AM
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology Yolowire 6:53 AM

-- December 4, 2025 --

Propanc Biopharma Investigates "Mesenchymal Drift" to Reverse Chronic Diseases Defined by Altos Labs Globe Newswire 8:45 AM

-- December 1, 2025 --

Propanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant Cancer and Fibrosis Globe Newswire 8:45 AM

-- November 17, 2025 --

Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results Globe Newswire 8:45 AM

-- November 10, 2025 --

Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company's R&D Pipeline Globe Newswire 8:45 AM

-- November 6, 2025 --

From Lab Bench to Blockchain: How Biotech is Reinventing Funding Yolowire 10:43 AM

-- November 4, 2025 --

Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV) Globe Newswire 7:00 AM

-- October 15, 2025 --

CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital Globe Newswire 5:45 PM
Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital Globe Newswire 8:45 AM

-- October 7, 2025 --

Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy Globe Newswire 8:45 AM

-- September 22, 2025 --

Crypto and Cancer: How Biotech's New Strategy Is Turning Heads Yolowire 2:59 PM

-- September 17, 2025 --

Propanc Biopharma Receives Certificate of Grant for "Proenzyme Composition" Patent from US Patent & Trademark Office Globe Newswire 8:45 AM

-- September 8, 2025 --

Stopping Cancer Before It Spreads: The EMT Revolution in Oncology Yolowire 3:43 PM
Stopping Cancer Before It Spreads: The EMT Revolution in Oncology Yolowire 7:15 AM

-- September 2, 2025 --

Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes